MS
Mississippi Senate Bill SB2733

Mississippi 2025 Regular Session

Mississippi Senate Bill SB2733

Introduced
1/20/25  
Refer
1/20/25  

Caption

NPLEx; require manufacturers of certain pseudoephedrine or ephedrine products to pay fees to support the administration of.

Latest MS SB2733 Activity

View All Events: MS 2025 Regular Session SB2733

Companion Bills

No companion bills found.

Previously Filed As

MS HB393

Pseudoephedrine and ephedrine; extend repealer on authority to sell and purchase without a prescription certain products containing.

MS SB2282

Pseudoephedrine; delete the automatic repealer on the provision that authorizes the distribution of.

MS SB2754

Pharmacy benefit managers; set certain requirements related thereto, including claim administration and reimbursements.

MS SB2441

Alternative nicotine products; prohibit distribution or sale of certain products.

MS SB2484

Pharmacy Benefit Manager; revise certain requirements of.

MS SB2886

Nicotine vapor device directory; require manufacturers to provide certification, set penalties and other provisions.

MS HB1676

Mississippi Intoxicating Hemp Regulation Act and Mississippi Medical Cannabis Act; revise certain provisions of.

MS HB338

Mississippi Retail Marijuana Act; create to authorize and regulate the personal use of marijuana.

MS HB615

Mississippi Retail Marijuana Act; create to authorize and regulate the personal use of marijuana.

MS HB1660

Cigarettes and vape products; require Commissioner of Revenue to establish separate directories to regulate sales of.

Similar Bills

MS HB1463

Pseudoephedrine; require manufacturers to pay fees to National Association of Drug Diversion Investigators to support NPLE.

MS HB393

Pseudoephedrine and ephedrine; extend repealer on authority to sell and purchase without a prescription certain products containing.

MS SB2282

Pseudoephedrine; delete the automatic repealer on the provision that authorizes the distribution of.

TX SB913

Relating to the transmission of records regarding over-the-counter sales of ephedrine, pseudoephedrine, and norpseudoephedrine and a person's civil liability for certain acts arising from the sale of those products.

TX HB1137

Relating to the transmission of records regarding over-the-counter sales of ephedrine, pseudoephedrine, and norpseudoephedrine and a person's civil liability for certain acts arising from the sale of those products.

MO SB726

Limits the sale or purchase of certain drugs

MO SB1485

Modifies the amount of certain drugs that may be sold or dispensed to an individual in a 12-month period

OR HB4025

Relating to pseudoephedrine; prescribing an effective date.